Skip to main content

Advertisement

Table 2 Patients’ data of prothesis

From: Treatment and outcome of malignant bone tumors of the proximal humerus: biological versus endoprosthetic reconstruction

Case Age (year)/gender Ennecking’s stage Specimen length (cm) Local recurrence (months) Pulmonary metastasis (months) Revisions (number, months) MSTS score (%) Follow-up time (months)
1 29/M Stage IIB 8.0 No No Aspetic loosening (1,68) 66 Alive, 120
2 37/M Stage IIA 9.5 No No Aspetic loosening (1,89) 73 Alive, 112
3 26/F Stage IIB 12.5 No No Aspetic loosening (1,76) 67 Alive, 105
4 18/M Stage IIB 13.0 No Conservative (20) --- 65 Death, 27
5 24/M Stage IIB 13.5 No No --- 65 Death, 76
6 41/F Stage IIA 10.3 No No Aspetic loosening (1,73) 71 Alive, 82
7 36/M Stage IIA 11.5 Amputation (16) No --- 56 Death, 41
8 20/M Stage IIB 12.5 No No Aspetic loosening (1,66) 67 Alive, 75
9 32/M Stage IIB 12.8 No Conservative (25) --- 60 Death, 34
10 28/F Stage IIA 10.5 No No Aspetic loosening (1,61) 62 Death, 69
11 31/F Stage IIB 8.5 No No --- 67 Alive, 60
12 25/F Stage IIB 10.5 No No Aspetic loosening (1,50) 61 Alive, 57
13 38/M Stage IIB 10.0 Amputation (23) No --- 51 Alive, 55
14 26/F Stage IIA 9.5 No No --- 58 Alive, 50
15 32/F Stage IIA 11.0 No No --- 63 Alive, 48
16 27/F Stage IIB 9.5 No Conservative (19) --- 72 Death, 26
17 31/M Stage IIB 12.5 No No Aspetic loosening (1,43) 63 Alive, 47
18 38/M Stage IIA 11.0 No No --- 64 Alive, 45
19 29/F Stage IIA 11.5 No No --- 56 Alive, 41
20 31/F Stage IIA 9.5 No Conservative (32) --- 67 Death, 35
21 23/M Stage IIB 10.2 No No Aspetic loosening (1,31) 62 Alive, 39
22 39/M Stage IIB 11.3 No No --- 67 Alive, 36
23 27/F Stage IIB 10.0 Amputation (19) No --- 53 Death, 32
24 25/M Stage IIA 12.5 No No --- 70 Alive, 35
25 28/F Stage IIA 13.0 No No --- 64 Alive, 30